Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

News [4199]

IMPAKT: Therapeutic effect and markers of response of palbociclib in HER2-positive breast cancer models

IMPAKT: Therapeutic effect and markers of response of palbociclib in HER2-positive breast cancer models

IMPAKT: Adoption of multi-gene assays in hormone receptor-positive, HER2-negative breast cancer

IMPAKT: Adoption of multi-gene assays in hormone receptor-positive, HER2-negative breast cancer

IMPAKT: Enzalutamide with or without an aromatase inhibitor for advanced breast cancer

IMPAKT: Enzalutamide with or without an aromatase inhibitor for advanced breast cancer

IMPAKT: Combination of mTOR and AKT inhibitors in patients with advanced breast cancer

IMPAKT: Combination of mTOR and AKT inhibitors in patients with advanced breast cancer

HRT impact on genes involved in breast cancer

HRT impact on genes involved in breast cancer

Lymph node ultrasounds more accurate in obese breast cancer patients, Mayo Clinic study finds

Lymph node ultrasounds more accurate in obese breast cancer patients, Mayo Clinic study finds

ASCO issues two new guidelines on treating patients with advanced, HER2-positive breast cancer

ASCO issues two new guidelines on treating patients with advanced, HER2-positive breast cancer

Half of all UK cancer patients now survive at least 10 years

Half of all UK cancer patients now survive at least 10 years

Open-access publishing has contributed to Africa's research output

Open-access publishing has contributed to Africa's research output

Receiving chemotherapy after a breast cancer diagnosis may affect a patient’s long-term employment

Receiving chemotherapy after a breast cancer diagnosis may affect a patient’s long-term employment

More from ecancer